Skip to content
April 19, 2024

Equity.Guru

Investment information for the new generation

Search

EU

Xphyto’s test may be ideal to catch the super-spreaders – the infectious carriers blithely attending drumming circles because they feel healthy….
“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto….
Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly….
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies….
Farmako GmbH, a subsidiary of Agraflora Organics International (AGRA.C), and ZenPharm, subsidiary of Zenabis Global (ZENA.T), joined into a binding supply term sheet, which serves as the basis for…
Xphyto Therapeutics’ (XPHY.C) potential deal with German brewery Oettinger Brauerei GmbH means development, production and distribution of cannabis-infused beverages for the European Market. They take their beer seriously in…
The financial crisis of 2007 wiped trillions off our global financial ledger. National economies reeled in the wake of banking’s biggest boo-boo since Reagan’s deregulation of the American Savings…
After an already success-filled year, CUV Ventures (CUV.V) finally crossed a financial goal line with RevoluPAY. RevoluPAY, CUV’s subsidiary, processed its first USD $25,000 worth of bookings for Expedia…
CUV Ventures’ (CUV.V) European expansion reached another milestone following news the company’s application to operate within the EU is currently under consideration. After the three month wait period has…
Germany’s medical marijuana market is lucrative, and Canadian LPs want in. Thankfully, Germany also wants Canadian companies to show them what’s up. Germany’s Shortage While Germany, the hottest cannabis…